Fri, Dec 22, 2017
Roche would pay $27 per share for Ignyta, representing a premium of about 74 percent to the stock`s closing price on Thursday, they said.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.